- Home
- MLYS vs SBLK Comparison
MLYS vs SBLK Comparison
Compare MLYS & SBLK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MLYS | SBLK |
|---|---|---|
| Founded | 2019 | 2006 |
| Country | United States | Greece |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Marine Transportation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.6B |
| IPO Year | 2023 | 2007 |
Fundamental Metrics
Financial Performance| Metric | MLYS | SBLK |
|---|---|---|
| Price | $23.86 | $22.77 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 1 |
| Target Price | ★ $48.67 | $22.00 |
| AVG Volume (30 Days) | 1.1M | ★ 2.0M |
| Earning Date | 03-12-2026 | 02-25-2026 |
| Dividend Yield | N/A | ★ 2.60% |
| EPS Growth | ★ 37.43 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $11.56 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $47.06 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $10.44 | $12.06 |
| 52 Week High | $47.65 | $27.20 |
Technical Indicators
Market Signals| Indicator | MLYS | SBLK |
|---|---|---|
| Relative Strength Index (RSI) | 32.42 | 45.84 |
| Support Level | $13.42 | $21.64 |
| Resistance Level | $31.09 | $27.20 |
| Average True Range (ATR) | 1.75 | 0.79 |
| MACD | -0.24 | -0.24 |
| Stochastic Oscillator | 15.31 | 28.42 |
Price Performance
Historical ComparisonAbout MLYS Mineralys Therapeutics Inc.
Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that is initially developed for the treatment of patients with uncontrolled hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking two or more lines of antihypertensive medication or resistant hypertension, typically including a diuretic.
About SBLK Star Bulk Carriers Corp.
Star Bulk Carriers Corp provides seaborne transportation solutions in the dry bulk sector. The company owns and operates dry bulk carrier vessels, which are used to transport bulk, such as iron ore, coal, grains, bauxite, fertilizers, and steel products. It owns a fleet of vessels that consists of Newcastlemax, Capesize, Post Panamax, Kamsarmax, Panamax, Ultramax, and Supramax. It generates revenues through the voyages it carries out.